FDA recall record

BioMylz Pvt Spring Valley Biotin & Collagen Liquid, Natural Berry Flavor recall — FDA F-0664-2024

Potential mold contamination

Class IIclassification
F-0664-2024official record ID
Jan 10, 2024report date

Recall record at a glance

Official recordF-0664-2024
CategoryFood Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmBioMylz Pvt. Ltd.
Report dateJan 10, 2024
Recall initiation dateDec 1, 2023
Quantity24,324 units
LocationBengaluru, N/A, India

Official product description

Spring Valley Biotin & Collagen Liquid, Natural Berry Flavor, 15000 mcg, Dietary Supplement 29 doses 1 fl oz (29mL) UPC: 194346065158 Packaged in a glass bottle in a paper carton

Why the product was recalled

Potential mold contamination

Distribution information

Distributed to a distribution center in CA and then further distributed to distribution centers and retail stores nationwide.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.